These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma. Steele G; Wang BS; Richie J; Wilson RE; Ervin T; Yankee R; Fallon M; Mannick JA Cancer Res; 1980 Jul; 40(7):2377-82. PubMed ID: 6155992 [No Abstract] [Full Text] [Related]
3. Status of adjuvant therapy for renal cell cancer. Sagalowsky A; Donohue J J Indiana State Med Assoc; 1979 Jul; 72(7):521-4. PubMed ID: 383849 [No Abstract] [Full Text] [Related]
4. The treatment of metastasis from renal cell carcinoma. Khoury S Prog Clin Biol Res; 1982; 100():541-7. PubMed ID: 7145983 [No Abstract] [Full Text] [Related]
5. [Treatment of metastasizing renal adenocarcinoma with specific plasma transfusion. A controlled trial of the effects on metastases and survival time]. Pedersen F; Hippe E; Hvidt V; Francis D; Jensen HS; Dybkjaer E; Rasmussen F Ugeskr Laeger; 1980 Nov; 142(48):3167-70. PubMed ID: 7003883 [No Abstract] [Full Text] [Related]
6. Immunological response to tumor ischemia in a murine renal cell carcinoma model. Edson Pontes J; Goldrosen M; Murphy GP Oncology; 1983; 40(1):63-6. PubMed ID: 6823406 [No Abstract] [Full Text] [Related]
7. [Treatment of advanced kidney adenocarcinoma]. Fosså S; Urianstad MK; Talle K Tidsskr Nor Laegeforen; 1975 May; 95(13):806-9. PubMed ID: 1135804 [No Abstract] [Full Text] [Related]
8. Proceedings: Current results from treatment of renal cell carcinoma. Murphy GP Proc Natl Cancer Conf; 1972; 7():751-9. PubMed ID: 4587662 [No Abstract] [Full Text] [Related]
9. Interferon and doxorubicin in renal cell carcinoma. Muss HB; Welander C; Caponera M; Reavis K; Cruz JM; Cooper MR; Jackson DV; Richards F; Stuart JJ; Spurr CL Cancer Treat Rep; 1985 Jun; 69(6):721-2. PubMed ID: 4016777 [No Abstract] [Full Text] [Related]
13. [Repetitive spontaneous retrogression of metastases. A contribution on the problem of the body's own defense against tumors]. von Salis-Samaden R Strahlentherapie; 1966 Jan; 129(1):26-31. PubMed ID: 5983028 [No Abstract] [Full Text] [Related]
14. Prognosis of renal adenocarcinoma in a central hospital. Arvola I; Lilius HG Ann Chir Gynaecol Fenn; 1972; 61(4):223-6. PubMed ID: 4640308 [No Abstract] [Full Text] [Related]
16. Clinical experiences in immunotherapy of cancer. Krementz ET; Samuels MS; Wallace JH; Benes EN Surg Gynecol Obstet; 1971 Aug; 133(2):209-17. PubMed ID: 5284416 [No Abstract] [Full Text] [Related]
17. Embolization and subsequent nephrectomy in metastatic renal cell carcinoma. Kurth KH; Cinqualbre J; Oliver RT; Schulman CC Prog Clin Biol Res; 1984; 153():423-36. PubMed ID: 6206510 [No Abstract] [Full Text] [Related]
18. Cancer of the kidney: diagnostic, therapeutic, and experimental vistas. The Percy T. Magan Memorial Lecture 1973. Kaufman JJ Med Arts Sci; 1973; 27(3):28-38. PubMed ID: 4594800 [No Abstract] [Full Text] [Related]
19. Treatment of metastatic hypernephroma. Talley RW; Moorhead EL; Tucker WG; San Diego EL; Brennan MJ JAMA; 1969 Jan; 207(2):322-8. PubMed ID: 5818154 [No Abstract] [Full Text] [Related]